1. Home
  2. IMRN vs TRUG Comparison

IMRN vs TRUG Comparison

Compare IMRN & TRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • TRUG
  • Stock Information
  • Founded
  • IMRN 1994
  • TRUG 1983
  • Country
  • IMRN Australia
  • TRUG United States
  • Employees
  • IMRN N/A
  • TRUG N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • TRUG
  • Sector
  • IMRN Health Care
  • TRUG
  • Exchange
  • IMRN Nasdaq
  • TRUG NYSE
  • Market Cap
  • IMRN 15.0M
  • TRUG 16.2M
  • IPO Year
  • IMRN N/A
  • TRUG N/A
  • Fundamental
  • Price
  • IMRN $1.90
  • TRUG $0.47
  • Analyst Decision
  • IMRN Strong Buy
  • TRUG Strong Buy
  • Analyst Count
  • IMRN 1
  • TRUG 1
  • Target Price
  • IMRN $5.00
  • TRUG $2.00
  • AVG Volume (30 Days)
  • IMRN 4.7K
  • TRUG 5.4M
  • Earning Date
  • IMRN 03-03-2025
  • TRUG 03-04-2025
  • Dividend Yield
  • IMRN N/A
  • TRUG N/A
  • EPS Growth
  • IMRN N/A
  • TRUG N/A
  • EPS
  • IMRN N/A
  • TRUG N/A
  • Revenue
  • IMRN $3,271,194.00
  • TRUG $21,917,131.00
  • Revenue This Year
  • IMRN N/A
  • TRUG $11.00
  • Revenue Next Year
  • IMRN N/A
  • TRUG $20.54
  • P/E Ratio
  • IMRN N/A
  • TRUG N/A
  • Revenue Growth
  • IMRN 171.67
  • TRUG 7.68
  • 52 Week Low
  • IMRN $1.65
  • TRUG $0.35
  • 52 Week High
  • IMRN $5.96
  • TRUG $2.27
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 43.76
  • TRUG 48.97
  • Support Level
  • IMRN $1.89
  • TRUG $0.36
  • Resistance Level
  • IMRN $2.05
  • TRUG $0.67
  • Average True Range (ATR)
  • IMRN 0.08
  • TRUG 0.05
  • MACD
  • IMRN -0.02
  • TRUG 0.01
  • Stochastic Oscillator
  • IMRN 3.85
  • TRUG 31.69

About IMRN Immuron Limited

Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About TRUG TRUGOLF HOLDINGS INC

TruGolf Holdings Inc is a indoor golf gaming solutions company. It has built video games ("Links"), innovative hardware solutions, and an all-new e-sports platform to connect golfers around the world with E6 CONNECT.

Share on Social Networks: